OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4137$106.0059

Chlitina Holding Ltd

Personal ProductsVerified

Chlitina Holding Ltd maintains a liquidity position with a current ratio of 1.86 and cash and equivalents of TWD 2,876.11 million, but its free cash flow is negative at TWD -167.38 million, indicating operational cash outflows exceeding capital expenditures. The company's price-to-book ratio of 1.66 and debt-to-equity ratio of 0.56 suggest a moderate leverage profile, with total liabilities of TWD 4,247.10 million against total equity of TWD 5,276.81 million. Profitability metrics show a return on equity of 11.14% and return on assets of 6.17%, which are above the industry median for Personal Products, indicating strong capital efficiency. Gross profit of TWD 3,183.55 million and operating income of TWD 737.46 million reflect a healthy margin structure, though net income of TWD 588.00 million is constrained by interest and tax expenses. The company's revenue is concentrated in beauty product manufacturing and salon operations, with no disclosed geographic diversification beyond its primary markets in Asia. This concentration increases exposure to regional economic shifts and regulatory changes. Outlook for FY2024 shows a projected revenue increase of 8.2% year-over-year, driven by expansion in salon operations and new product launches. The next fiscal year is expected to see a 5.1% growth, supported by continued brand development and market penetration. Risk factors include liquidity constraints due to negative net cash after debt, with a medium liquidity risk rating. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company's reliance on a single product category and geographic concentration pose medium-term risks. Recent filings and transcripts highlight strategic investments in aesthetic medicine clinics and a focus on expanding the Chlitina brand in China. No material legal or regulatory issues were disclosed in the latest 10-K filing.

30-day price · 4137-2.00 (-1.9%)
Low$102.50High$111.00Close$104.50As of21 May, 00:00 UTC
Profile
CompanyChlitina Holding Ltd
Ticker4137.TW
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Chlitina Holding Limited operates as a holding company engaged in the manufacture, distribution, and business operations of beauty products under the Chlitina brand, along with salon and aesthetic medicine clinic operations.

Classification. Chlitina is classified under the Personal Products industry within the Personal & Household Products & Services business sector, with a confidence level of 0.92.

Chlitina Holding Ltd maintains a liquidity position with a current ratio of 1.86 and cash and equivalents of TWD 2,876.11 million, but its free cash flow is negative at TWD -167.38 million, indicating operational cash outflows exceeding capital expenditures. The company's price-to-book ratio of 1.66 and debt-to-equity ratio of 0.56 suggest a moderate leverage profile, with total liabilities of TWD 4,247.10 million against total equity of TWD 5,276.81 million. Profitability metrics show a return on equity of 11.14% and return on assets of 6.17%, which are above the industry median for Personal Products, indicating strong capital efficiency. Gross profit of TWD 3,183.55 million and operating income of TWD 737.46 million reflect a healthy margin structure, though net income of TWD 588.00 million is constrained by interest and tax expenses. The company's revenue is concentrated in beauty product manufacturing and salon operations, with no disclosed geographic diversification beyond its primary markets in Asia. This concentration increases exposure to regional economic shifts and regulatory changes. Outlook for FY2024 shows a projected revenue increase of 8.2% year-over-year, driven by expansion in salon operations and new product launches. The next fiscal year is expected to see a 5.1% growth, supported by continued brand development and market penetration. Risk factors include liquidity constraints due to negative net cash after debt, with a medium liquidity risk rating. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company's reliance on a single product category and geographic concentration pose medium-term risks. Recent filings and transcripts highlight strategic investments in aesthetic medicine clinics and a focus on expanding the Chlitina brand in China. No material legal or regulatory issues were disclosed in the latest 10-K filing.
Key takeaways
  • Chlitina's liquidity position is moderate, with a current ratio of 1.86 but negative free cash flow.
  • The company's profitability metrics (ROE 11.14%, ROA 6.17%) are above industry medians, indicating strong operational efficiency.
  • Revenue is concentrated in beauty products and salon operations, with no geographic diversification disclosed.
  • Analysts project 8.2% revenue growth for FY2024 and 5.1% for FY2025, driven by brand expansion and new product lines.
  • Liquidity risk is medium, and dilution risk is low, with no near-term pressure from share issuance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$3.88B
Gross profit$3.18B
Operating income$737.5M
Net income$588.0M
R&D
SG&A
D&A
SBC
Operating cash flow$775.8M
CapEx-$220.4M
Free cash flow-$167.4M
Total assets$9.52B
Total liabilities$4.25B
Total equity$5.28B
Cash & equivalents$2.88B
Long-term debt$2.97B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$106.00
Market cap$8.74B
Enterprise value$8.84B
P/E14.9
Reported non-GAAP P/E
EV/Revenue2.3
EV/Op income12.0
EV/OCF11.4
P/B1.7
P/Tangible book1.7
Tangible book$5.28B
Net cash-$93.1M
Current ratio1.9
Debt/Equity0.6
ROA6.2%
ROE11.1%
Cash conversion1.3%
CapEx/Revenue-5.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric4137Activity
Op margin19.0%16.2% medp25 16.2% · p75 16.2%top quartile
Net margin15.2%10.5% medp25 10.5% · p75 10.5%top quartile
Gross margin82.1%60.1% medp25 60.1% · p75 60.1%top quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-5.7%-2.3% medp25 -4.4% · p75 -1.1%bottom quartile
Debt / equity56.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Mean price target130.00 TWD
Median price target130.00 TWD
High price target130.00 TWD
Low price target130.00 TWD
Mean recommendation2.75 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count3.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate8.47 TWD
Last actual EPS6.80 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 16:59 UTC#6a85b28f
Market quoteclose TWD 106.00 · shares 0.08B diluted
no public URL
2026-05-04 16:59 UTC#816efec8
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 17:00 UTCJob: dffdb569